Introduction {#sec1}
============

Primordial germ cells (PGCs) are the founders of germ cells that give rise to eggs and sperm as the end products ([@bib39]). In mice, extraembryonic tissues direct a small number of pluripotent epiblast cells to express interferon-induced transmembrane protein 3 (Ifitm3) as PGC precursors by providing bone morphogenetic protein 4 (BMP4) growth factor ([@bib35]). WNT3A is required for the responsiveness of epiblast cells to BMP4 ([@bib31]). Following BMP4 signaling, approximately 40 cells in the posterior-proximal extraembryonic mesoderm begin to express Stella, which permits the specification of PGCs. During PGC specification from the pluripotent epiblast cells, it is crucial to repress the somatic program ([@bib35]). Thereafter, PGCs migrate along the hindgut into the genital ridges concomitantly with an extensive genome-wide epigenetic reprogramming, including alteration of histone modification and erasure of imprinted loci ([@bib16]). Another key event during mouse germline specification is the expression of pluripotency-associated genes such as *Pou5f1* (*Oct3/4*), *Sox2*, and *Nanog* ([@bib43]). However, human PGCs appear to express only OCT4 and NANOG, and not SOX2 ([@bib33]), indicating the possibility of interspecies differences in germline development and an unidentified mode of action of pluripotency-associated genes in germline commitment.

The transcriptional repressor PRDM1, also known as B lymphocyte-induced maturation protein-1 (Blimp-1), was identified as the key regulator of the differentiation of mature B lymphocytes into antibody-producing plasma cells ([@bib36]). It is also expressed and required for mouse embryonic development as well as for the differentiation of many adult cell lineages ([@bib3]). It is of importance that, in mouse, some Prdm1-expressing cells can be traced in the inner cell mass (ICM) and used to predict the outgrowth of PGCs ([@bib7]), in which the sustained expression of Prdm1 permits the generation of PGCs at embryonic day 6.25 (E6.25) in proximal posterior epiblast cells ([@bib30]). It has been noted that Prdm1 is crucial for the specification of PGCs in early mouse development because mice lacking *Prdm1* produce rare PGCs that are unable to migrate ([@bib30; @bib41]). Prdm1 temporally associates with an arginine-specific histone methyltransferase, Prmt5, to establish epigenetic changes during mouse germ cell development ([@bib1]). Whether PRDM1 is expressed and plays a role in human germline specification remains elusive.

Embryonic stem cells (ESCs) provide a valuable tool to elucidate the molecular mechanisms underlying the developmental path of cellular lineages, particularly with regard to human development. PGCs can be derived from pluripotent mouse ESCs or human ESCs (hESCs) ([@bib8; @bib14; @bib21]). Furthermore, hESCs or human induced pluripotent stem cells (hiPSCs) were recently directed into adult-type postmeiotic spermatogenic cells with largely improved frequencies ([@bib11]). Due to ethical issues involving the fact that the precursors of human PGCs are practically inaccessible in vivo, as they colonize between 5 and 8 weeks of gestation ([@bib9; @bib12]), hESCs have become an important tool for producing potential PGCs in vitro. Therefore, it is important to develop improved methods to isolate and generate human PGCs or functional gametes from hESCs. For instance, manipulation of gene expression in hESCs, such as overexpression of deleted in azoospermia-like (DAZL) or silencing DAZL, affects the formation of cells expressing VASA ([@bib24]), the postmigratory PGC marker ([@bib4]).

Herein, we examine whether PRDM1 is expressed by human PGCs and involved in human germline differentiation. We show that PRDM1 is expressed in the second trimester of human embryonic ovary and testis development. Additionally, using hESCs as the differentiating platform, we show that PRDM1 is necessary and sufficient for the formation of hESC-derived germline cells, which may be attributed to the role of PRDM1, at least partly, in the suppression of *SOX2*.

Results {#sec2}
=======

PRDM1 Is Expressed in Early Human Fetal Gonads {#sec2.1}
----------------------------------------------

We first examined the expression of PRDM1 in various human embryonic organs. [Figure 1](#fig1){ref-type="fig"}A shows that PRDM1 was predominantly expressed in human fetal testis collected from an 18-week-old abortus, as demonstrated by immunohistochemistry (IHC) staining with anti-PRDM1 antibody. However, PRDM1 immunopositive signals, which were stained in nuclei, were not detected in human fetal liver, lung, heart, and kidney ([Figure 1](#fig1){ref-type="fig"}A), supporting previous findings obtained in mice ([@bib5]). Of note, in fetal testis, PRDM1 is expressed in enclosed seminiferous cords ([Figure 1](#fig1){ref-type="fig"}A).

Next, to verify the cell lineage expressing PRDM1 in fetal gonads, we collected embryonic germline tissues from 16- to 22-week-old human fetal gonads to analyze the expression of OCT4, VASA, and PRDM1 by IHC staining. Here, OCT4 was used as the indicator for PGCs ([@bib25]). We found that PRDM1^+^ cells appeared to be round and small, and located in the cortex of the ovary ([Figure 1](#fig1){ref-type="fig"}B, a and f). OCT4 immunopositive signals, which were present in nuclei, were also detected in the ovarian cortex ([Figure 1](#fig1){ref-type="fig"}B, b and g). In fetal testis, the PRDM1^+^ and OCT4^+^ cells were enclosed in the seminiferous cords ([Figure 1](#fig1){ref-type="fig"}B, k-l and p-q). Indeed, double stains of PRDM1 and OCT4 revealed that a large proportion of PRDM1^+^ cells overlapped with OCT4^+^ cells in either fetal ovary or testis ([Figure 1](#fig1){ref-type="fig"}B, c, h, m, and r). In contrast, the majority of PRDM1^+^ cells or OCT4^+^ cells were not coexpressed with cells stained strongly by anti-VASA antibody ([Figure 1](#fig1){ref-type="fig"}B, d-e, i-j, n-o, and s-t). Because VASA is the hallmark of postmigrating germ cells ([@bib4]), we suspected that PRDM1 might be involved in early human PGC commitment.

PRDM1 Is Expressed in hESC-Derived Germ Cells {#sec2.2}
---------------------------------------------

Next, we used hESCs as an in vitro model to examine the expression of PRDM1 in human germline differentiation. We used two hESC lines: H9 hESCs and previously established NTU1 hESCs, which possess the potential to spontaneously differentiate into germ cells ([@bib6]). H9 hESCs were plated for spontaneous differentiation, and cells were harvested for quantitative RT-PCR (qRT-PCR) and immunofluorescence staining with antibodies against PRDM1 and various markers associated with germline lineages. *PRDM1* mRNA was readily induced following spontaneous differentiation of H9 hESCs and showed induction kinetics to similar to those of *NANOS3*, which is important for maintaining PGCs ([@bib22]). The induction of *PRDM1* also preceded the expression of *VASA* and synaptonemal complex protein 3 (*SCP3*), a marker for meiosis ([@bib28]; [Figure 2](#fig2){ref-type="fig"}A). Immunofluorescence staining showed that PRDM1 began to express at day 5 and was primarily coexpressed with STELLA and NANOS3, which is important for guiding PGC migration in vivo ([@bib40]; [Figure 2](#fig2){ref-type="fig"}B). The level of PRDM1 was enriched at day 10, at which time the majority of PRDM1^+^ cells were also OCT4^+^ ([Figure 2](#fig2){ref-type="fig"}B and [Figure S1](#app3){ref-type="sec"}A available online). However, VASA^+^ cells became prominent by day 20 ([Figure S1](#app3){ref-type="sec"}B) and excluded the expression of PRDM1 ([Figure 2](#fig2){ref-type="fig"}B). Likewise, following spontaneous differentiation of NTU1 hESCs, *PRDM1* and *NANOS3* mRNA was significantly increased before upregulation of *VASA* and *SCP3* occurred ([Figure 2](#fig2){ref-type="fig"}C). Immunofluorescence staining showed that PRDM1 was coexpressed with OCT4 at days 5 and 10 ([Figures 2](#fig2){ref-type="fig"}D and [S1](#app3){ref-type="sec"}A), and with STELLA and NANOS3 at day 5, but the majority of VASA^+^ cells did not coexpress with PRDM1 at day 20 ([Figure 2](#fig2){ref-type="fig"}D). The significant induction of *PRDM1* before the induction of *VASA* and *SCP3* was also observed in NTU1 hESCs plated for spontaneous differentiation by two other protocols ([Figures S1](#app3){ref-type="sec"}C and S1D).

In parallel, we validated the expression of PRDM1 in enriched germline cells derived from differentiating hESCs using a stable hES transfectant that carried an *OCT4*-EGFP transgene reporter, H9:*OCT4*-EGFP ([@bib8]). The reporter hESCs were plated for spontaneous differentiation and then the EGFP^+^ cells representing the progeny of germline lineage at days 15 and 30 were sorted ([Figure S1](#app3){ref-type="sec"}E). Indeed, in comparison with the undifferentiated hESCs, sorted EGFP^+^ H9:*OCT4*-EGFP cells expressed higher levels of *VASA* and *PRDM1* mRNA ([Figure 2](#fig2){ref-type="fig"}E), indicating that PRDM1 is enriched in hESC-derived germ cells. Consistently, certain OCT4^+^ (EGFP^+^) cells were also PRDM1^+^/STELLA^+^ or PRDM1^+^/NANOS3^+^ ([Figure S1](#app3){ref-type="sec"}F).

Taken together, these results indicate that PRDM1 expression is indicative of early germline lineage derived from differentiating hESCs.

PRDM1 Is Required for BMP4- and WNT3A-Induced Germ Cell Differentiation {#sec2.3}
-----------------------------------------------------------------------

To facilitate germ cell formation in culture, H9 hESCs were treated with BMP4 and WNT3A ([@bib8; @bib31]). Immunofluorescence staining showed that a subset of cells expressed PRDM1 5 days after exposure to BMP4 and WNT3A, whereas undifferentiated hESCs did not express PRDM1, and a large proportion of PRDM1^+^ cells were also OCT4^+^ cells ([Figures 3](#fig3){ref-type="fig"}A and [S2](#app3){ref-type="sec"}A). At day 20, some cells expressed VASA ([Figure S2](#app3){ref-type="sec"}B), but they did not coexpress with PRDM1 ([Figure 3](#fig3){ref-type="fig"}A). Consistently, like the early induction of *NANOS3*, *PRDM1* mRNA was induced most pronouncedly at day 5 following treatment with BMP4 and WNT3A ([Figure 3](#fig3){ref-type="fig"}B). Similarly, the induction of *PRDM1* mRNA occurred prior to the induction of *VASA* and *SCP3* ([Figure 3](#fig3){ref-type="fig"}B). It is noted that treatment with NOGGIN and/or dickkopf-1 (DKK1), the inhibitors of BMPs and canonical Wnt signaling, respectively, suppressed the induction of *PRDM1* and *NANOS3* mRNA at day 5 ([Figure 3](#fig3){ref-type="fig"}C), suggesting that the induction of PRDM1 depends on BMP4 and WNT3A signaling in germline development in vitro.

To determine whether the induction of PRDM1 is crucial for germline formation, we transduced H9 hESCs with lentiviral vectors producing small hairpin RNA (shRNA) against PRDM1, or control shRNA (shControl). The induction of *PRDM1* mRNA was impaired in PRDM1 knockdown (PRDM1-KD) cells after treatment with BMP4 and WNT3A ([Figure 3](#fig3){ref-type="fig"}D). It is noted that, compared with shControl-expressing cells, the mRNA levels of *STELLA*, *NANOS3, VASA*, and *SCP3* were reduced in PRDM1-KD cells ([Figures 3](#fig3){ref-type="fig"}D and [S2](#app3){ref-type="sec"}C). Likewise, immunofluorescence staining showed that shControl-transduced (GFP^+^) H9 hESCs expressed PRDM1 and VASA in response to BMP4 and WNT3A signaling at days 5 and 10, respectively, whereas the expression of both proteins was dampened in PRDM1-KD cells ([Figures 3](#fig3){ref-type="fig"}E and [S2](#app3){ref-type="sec"}D). These data show that PRDM1 is necessary for BMP4- and WNT3A-induced germ cell fate in vitro.

PRDM1 Promotes Germline Differentiation of hESCs {#sec2.4}
------------------------------------------------

Given that PRDM1 is important for germline fate driven by BMP4 and WNT3A treatment in hESCs, we wondered whether the BMP4- and WNT3A-induced germ cell formation could be further enhanced by overexpression of PRDM1. H9 hESCs were transduced with lentiviral vectors encoding GFP-PRDM1 or GFP and then treated with BMP4 and WNT3A. As shown in [Figures 4](#fig4){ref-type="fig"}A and [S2](#app3){ref-type="sec"}C, a small portion (4.5%) of GFP control vector-transduced H9 cells expressed VASA 12 days after treatment with BMP4 and WNT3A. To our surprise, combined treatment with BMP4/WNT3A and GFP-PRDM1 expression synergistically enhanced the expression of VASA ([Figures 4](#fig4){ref-type="fig"}A and [S2](#app3){ref-type="sec"}E), suggesting that ectopic PRDM1 expression can further promote the effect of BMP4 and WNT3A. It is noteworthy that treatment with BMP4 and WNT3A along with PRDM1 overexpression generated more cells expressing punctate and elongated SCP3 ([Figures 4](#fig4){ref-type="fig"}B and 4C). Supporting this finding, fluorescence in situ hybridization (FISH) analysis with probes for chromosomes 16 and X on GFP-PRDM1 or GFP-expressing and BMP4/WNT3A-treated cells revealed that ectopic expression of GFP-PRDM1 resulted in a small percentage of cells (0.67%) having only a single staining signal for both probes (haploid), whereas the chromosome contents of GFP-expressing cells were all diploid ([Figure 4](#fig4){ref-type="fig"}D). In combination, these results indicate that ectopic expression of PRDM1 together with the exposure to BMP4 and WNT3A facilitated the generation of germ cells with meiotic properties.

Because Prdm1-expressing cells in the ICM are predisposed to a PGC fate in mice ([@bib7]), we wondered whether overexpression of PRDM1 in hESCs is sufficient to enhance the outburst of germ cells. Lentiviral vectors producing GFP-PRDM1 fusion protein or GFP were used to transduce H9 hESCs that were maintained in ES media and cocultured with feeder cells. Of note, in contrast to GFP, forced expression of GFP-PRDM1 in H9 hESCs resulted in a subset of cells expressing STELLA, NANOS3, or VASA at week 2 ([Figure 5](#fig5){ref-type="fig"}A), suggesting that enforced PRDM1 expression in hESCs upregulated these markers. In parallel, GFP^+^ or GFP-PRDM1^+^ cells were harvested and subjected to analysis of expression of several germ cell markers by qRT-PCR. Accordingly, the mRNA levels of several germline markers, such as *SSEA1*, *NANOS3*, and VASA, were increased, whereas *DNMT3b* mRNA was reduced, in GFP-PRDM1-expressing cells compared with GFP-expressing cells ([Figure 5](#fig5){ref-type="fig"}B).

To further establish whether hESCs expressing ectopic GFP-PRDM1 displayed a gene-expression signature similar to that observed in the germline lineages, we compared the transcription profiles of H9 hESCs transduced with GFP-PRDM1 and GFP control vectors on days 7 and 17 with data sets derived from hESCs and hiPSCs ([@bib20]), human fetal testis and ovary tissues ([@bib19]), and differentiated tissues of human adults ([@bib37]). We found that 1,071 genes were selectively expressed in GFP-PRDM1 vector-transduced cells ([Table S1](#mmc2){ref-type="supplementary-material"}). Gene Ontology (GO) analysis of these differentially expressed genes revealed that the top ten enriched GO categories were majorly involved in the processes of development, differentiation, proliferation, and signaling ([Figure 5](#fig5){ref-type="fig"}C; [Table S2](#mmc3){ref-type="supplementary-material"}). We then projected the 1,071-dimensional transcription profiles of 216 experiments into a two-dimensional plane using nonclassical multidimensional scaling (MDS). Strikingly, the results in [Figure 5](#fig5){ref-type="fig"}D indicate that the developmental specification from hESCs toward germ cells following PRDM1 expression is reflected by the global gene-expression patterns. The data points from left to right correspond to the experiments with hESCs and hiPSCs, hESCs transduced with GFP-PRDM1, and fetal gonads. This trend is also pronounced by the average correlation coefficients between transcription from our experiments and three other studies in [Figure 5](#fig5){ref-type="fig"}D ([Table S3](#app3){ref-type="sec"}).

We then analyzed the average correlation coefficients of global gene-expression profiles between GFP- and GFP-PRDM1-transduced H9 cells and fetal ovary or testis tissues along with developmental time points. In both ovary and testis, correlation coefficients with GFP-PRDM1-transduced cells unequivocally decreased with time. In contrast, the correlation coefficients with GFP-transduced cells exhibited only moderate dependencies with time. Furthermore, the correlation coefficients with the average expression profiles of differentiated adult tissues exhibited weak dependencies with time ([Figure 5](#fig5){ref-type="fig"}E). To ensure the similarities in global expression profiles between GFP-PRDM1 cells and gonad samples were attributed to germ cells, we calculated the expression profile correlation coefficients between four adult testis substructures in the data set of adult tissues ([@bib37]), and PRDM1-treated and control H9 hESCs ([Table S3](#app3){ref-type="sec"}). GFP-PRDM1-transduced cells had the highest average correlation coefficient to germ cells (0.176), followed by Leydig cells (0.138), seminiferous tubules (0.131), and interstitial cells (0.119). These results suggest that the global gene-expression profiles of GFP-PRDM1-transduced hESCs resemble those of the early stage of germ cells.

PRDM1 Directly Suppresses *SOX2* Expression {#sec2.5}
-------------------------------------------

We then examined whether the expression of pluripotent genes was affected after ectopic expression of GFP-PRDM1 in H9 hESCs. Interestingly, *OCT3/4* and *NANOG* mRNA levels were only marginally affected, but *SOX2* mRNA levels were significantly reduced in GFP-PRDM1-expressing cells, when compared with GFP-expressing cells ([Figure 6](#fig6){ref-type="fig"}A). This finding was further verified by immunofluorescence staining, which showed that GFP-PRDM1^+^ cells displayed strikingly less SOX2 compared with GFP^+^ cells, but the majority of PRDM1^+^ cells remained to coexpress with OCT4 and NANOG, 7 days after lentiviral transduction ([Figure 6](#fig6){ref-type="fig"}B). To further clarify this observation, we transduced three human embryonal carcinoma (EC) lines (PA-1, NTERA-2 and NCCIT cells) with GFP- or GFP-PRDM1-expressing lentiviral vectors. Consistently, SOX2 mRNA and protein were dramatically repressed by exogenous PRDM1 in all three EC lines, whereas the expression of OCT4 and NANOG was only marginally influenced ([Figure S3](#app3){ref-type="sec"}), suggesting that *SOX2* is likely suppressed by PRDM1. Indeed, seven potential PRDM1-binding sites between the genomic region of −4.4 Kb and transcriptional start site of human *SOX2* gene were found, according to the 12 bp consensus binding site, GTAGTGAAAGTG, determined previously ([@bib26]; [Figure 6](#fig6){ref-type="fig"}C). Chromatin immunoprecipitation (ChIP) assay using chromatins prepared from NCCIT EC cells expressing GFP-PRDM1 or GFP and anti-PRDM1 antibody demonstrated that PRDM1 bound to some of these predicted sites ([Figure 6](#fig6){ref-type="fig"}D). The *CIITA* gene was used as the positive control locus ([@bib38]), and the 3′ UTR of *SOX2* and *CIITA* loci was used as the negative control ([Figure 6](#fig6){ref-type="fig"}D). Moreover, we constructed luciferase reporters fused with the 5′ regulatory region, located between −4.4 Kb and +268 of human *SOX2* containing all seven potential PRDM1-binding sites (*SOX2*-Luc) or other various lengths of the 5′ flanking region of *SOX2* ([Figure 6](#fig6){ref-type="fig"}E), in order to dissect the major PRDM1-binding site(s) that can contribute to the suppression of *SOX2*. [Figure 6](#fig6){ref-type="fig"}E shows that PRDM1 suppressed the luciferase activity regulated by the −4.4 Kb 5′ regulatory region of human *SOX2* (a). The luciferase reporter construct deleting sites 1, 2, and 3 of the *SOX2* 5′ flanking region (b) was suppressed significantly less by PRDM1, whereas deletion of an additional region containing site 4 (c) did not reveal further repression ([Figure 6](#fig6){ref-type="fig"}E). Further deletion of the *SOX2* 5′ flanking region composed of sites 1--5 (d) rendered the luciferase activity refractory to PRDM1 suppression ([Figure 6](#fig6){ref-type="fig"}E). Lastly, luciferase activity driven by the −1.5 Kb 5′ regulatory region of *SOX2*, which lacks either sites 1--6 or all seven potential PRDM1-binding sites (e and f, respectively), were resistant to PRDM1 suppression ([Figure 6](#fig6){ref-type="fig"}E). To further validate these findings, we mutated sites 1, 2, and/or 3 in construct (a) by site-directed mutagenesis. We found that when sites 1/2 and 1/2/3 were simultaneously, but not individually, mutated, PRDM1-mediated repression of the *SOX2* promoter activity was reduced ([Figure 6](#fig6){ref-type="fig"}F). These data suggested that sites 1, 2, and 3 (primarily sites 1 and 2) on the *SOX2* 5′ flanking region are involved in PRDM1-mediated transcriptional repression. Together, these data show that germline specification in hESCs triggered by the expression of PRDM1 is linked with the suppression of *SOX2*.

Suppression of *SOX2* Is Required for Germline Differentiation In Vitro {#sec2.6}
-----------------------------------------------------------------------

In addition to ESCs, SOX2 is expressed in neuroectoderm and is a functional marker of neural lineages ([@bib15]). Since PRDM1 suppresses *SOX2*, we wondered whether BMP4- and WNT3A-mediated induction of PRDM1, which favors germline differentiation, participates in the suppression of neural differentiation. Indeed, BMP4 and WNT3A treatment of H9 hESCs resulted in the downregulation of *PAX6*, the neural marker ([@bib44]; [Figure S4](#app3){ref-type="sec"}), as well as *SOX2* ([Figure 7](#fig7){ref-type="fig"}A). We thus analyzed the expression of several neural markers ([@bib18]), including SOX1, LHX2, NESTIN, TUJ1, and MAP2, in PRDM1-KD H9 hESCs treated with BMP4 and WNT3A. We found that PRDM1-KD led to increased *SOX2* mRNA and protein ([Figures 7](#fig7){ref-type="fig"}A and [S5](#app3){ref-type="sec"}A), consistent with the notion that PRDM1 directly represses *SOX2*. Interestingly, the mRNA levels of several neural genes, such as *SOX1*, *PAX6*, *NESTIN*, and *MAP2*, but not *LHX2*, were all elevated in PRDM1-KD cells at various time points ([Figure 7](#fig7){ref-type="fig"}A). Immunofluorescence staining results also showed that PRDM1-KD GFP^+^ cells exhibited stronger signals for the neural markers SOX1, NESTIN, TUJ1, and MAP2 after treatment with BMP4 and WNT3A, as compared with shControl-transduced GFP^+^ cells ([Figure 7](#fig7){ref-type="fig"}B). These data suggested that BMP4- and WNT3A-induced PRDM1 not only drives germ cell differentiation but also prohibits the neural program.

Given that downregulation of *SOX2* is linked with human germ cell differentiation, we wondered whether ectopic expression of SOX2 in hESCs blocks BMP4- and WNT3A-mediated germline differentiation. H9 hESCs stably expressing control GFP or SOX2 and GFP simultaneously were established for this purpose ([Figures S5](#app3){ref-type="sec"}B--S5E). Four weeks after ectopic expression of SOX2, H9 hESCs cultured in ES media showed slightly increased numbers of SOX1^+^, LHX2^+^, PAX6^+^, and NESTIN^+^ cells as compared with control GFP-expressing H9 hESCs ([Figure S5](#app3){ref-type="sec"}E). Endogenous *SOX2* was rapidly decreased in control GFP^+^ cells at day 5 after BMP4 and WNT3A treatment, whereas the expression of exogenous SOX2 was sustained during differentiation ([Figure 7](#fig7){ref-type="fig"}C). It is noted that in the presence of exogenous SOX2, induction of *PRDM1* at day 5 and *VASA* at day 20 after BMP4 and WNT3A treatment was perturbed as compared with control GFP-expressing cells ([Figure 7](#fig7){ref-type="fig"}C). qRT-PCR or immunofluorescence staining showed that the expression levels of neural markers, including SOX1, LHX2, TUJ1, and MAP2, were elevated in SOX2-overexpressing cells ([Figures 7](#fig7){ref-type="fig"}C and 7D). These data suggest that SOX2 impedes germ cell differentiation induced by BMP4 and WNT3A, and redirects the germline-committed hESCs toward a neural fate.

Discussion {#sec3}
==========

Here, we provide evidence showing the expression of PRDM1 in human fetal germline tissues. Although it has been reported that Prdm1 is absent in zebrafish PGCs ([@bib29]), the expression of PRDM1 in the germ cell lineage appears to be evolutionarily conserved between mouse and human. In the mouse germline, Prdm1 expression was found in several developmental stages: the ICM, proximal epiblast PCG precursors, and migrating PGCs along the hindgut and primitive gonadal ridge ([@bib5; @bib7; @bib30]). Although in this study we were unable to demonstrate whether PRDM1 is expressed in human PGC precursors, as their formation occurs between 5 and 8 weeks of gestation ([@bib9; @bib12]), we showed that PRDM1 is expressed in the second trimester of fetal gonads. Given that PRDM1 is coexpressed with OCT4, but not with the migratory germ cell marker VASA, in the developing human fetal testis or ovary of second-trimester abortus, it is plausible that the PRDM1-expressing cells in human fetal gonads are newly immigrating PGCs that can further differentiate into late germline progenitors/germ cells. Supporting this finding, it has been reported that OCT4 is expressed in a subpopulation of germ cells where the PGCs reside in testis cords in the second trimester of human testis development ([@bib13]). Consistent with the in vivo observation, our in vitro differentiation studies demonstrated that PRDM1 is coexpressed with other germ cell markers in differentiating hESCs in early differentiation stages (days 5 and 10), but is not coexpressed with VASA in the late stage (day 20), although VASA has been detected in the fetal germline population as early as 7 weeks of gestation ([@bib4]). This could be due to the heterogeneous nature of early germline development, and cells with different expression patterns of germline markers may represent a different subpopulation of germline progenitors that give rise to a larger population of VASA-expressing cells at later developmental stages.

The functional role of BMP/Smad and Wnt/β-catenin signaling pathways in early germ cell formation has been studied extensively in mice ([@bib31]). It was demonstrated that only a subset of WNT3A-expressing epiblast cells of E5.5--E6.25 embryos respond to BMPs secreted from their surrounding extraembryonic cells, thereby acquiring the competence of early germ cells ([@bib31]). Similar to these findings in mice, we previously demonstrated that BMP4 and WNT3A treatment significantly enhances the potential of germline differentiation by hESCs ([@bib8]). These observations led us to investigate the importance of BMP and/or Wnt signaling for PRDM1 induction in germline differentiation of hESCs. Indeed, we showed that BMP4 and WNT3A significantly increased the expression of germline-related marker genes as well as PRDM1, whereas blocking the activation of either BMP or Wnt signaling with their antagonists significantly reduced the expression of PRDM1. Furthermore, the germline potential was evidently impaired in PRDM1-KD hESCs after BMP4 and WNT3A treatment, suggesting that PRDM1 is most probably a crucial downstream effector of germline inducers such as BMP and Wnt signaling molecules. Thus, these results suggest an evolutionarily conserved BMP4/PRDM1 regulatory axis between human and mouse in controlling germ cell specification. Although we demonstrated BMP4-dependent PRDM1 induction, the mechanism by which BMP signaling activates PRDM1 is still elusive. It was previously suggested that, in mouse, BMP signals may upregulate *Prdm1* via BMP-dependent activation of Smad1 and Smad5 ([@bib31]). Further studies are necessary to determine whether SMAD proteins directly regulate *PRDM1* during human germline differentiation.

During mouse PGC specification, Prdm1 served as a key transcriptional regulator responsible for repression of the somatic program and establishment of germline characteristics, including upregulation of pluripotency-associated genes such as *Oct3/4*, *Nanog*, and *Sox2*, in the PGC precursors ([@bib27]). We showed that ectopic expression of PRDM1 in hESCs downregulated SOX2 expression, but had no effect on the expression of OCT4 and NANOG. Further, combined ChIP and reporter assay analyses showed that PRDM1 directly targets the promoter of *SOX2* and represses its transcription. However, these results also reveal a discrepancy between human and mouse in terms of the PRDM1-mediated germline specification. Sox2 is expressed in mouse germ cells ([@bib34]), whereas it is absent from human PGCs and gonocytes during the early stage of human development ([@bib33]). The functional significance of the absence of SOX2 from early human germ cells remains unclear. We show here that overexpression of SOX2 in hESCs under the condition favoring germline differentiation reduced the production of VASA^+^ cells, suggesting that SOX2 may perturb the expression of germline-associated genes. In hESCs, the SOX family proteins SOX2 and SOX3 are redundant and repress mesendoderm differentiation ([@bib42]). It is thus plausible that in human, other SOX proteins may provide substitutive functions that similarly mimic the action of SOX2 in mouse for modulating germline formation. Supporting this notion, SOX17 was found to be coexpressed with OCT4 in early human germ cells ([@bib10]). This observation further suggests that SOX17 may play a role in conjunction with other factors, such as OCT4, in the generation of human germ cells.

The functional roles of SOX2 in human pluripotency maintenance and lineage differentiation were recently reported ([@bib42]). SOX2 is not essential for hESC self-renewal. However, overexpression of SOX2 results in the promotion of neural ectodermal differentiation and the suppression of definitive endodermal differentiation in hESCs under in vitro differentiation ([@bib42]). In agreement with these findings, we found that the neural program, including the expression of SOX1, LHX2, and NESTIN, was upregulated in hESCs overexpressing SOX2 ([Figure S5](#app3){ref-type="sec"}E). Furthermore, our results demonstrated that the germline program was suppressed under the same condition, suggesting an opposing role of SOX2 in directing human neural and germ cell fate. Thus, it is tempting to speculate that PRDM1 may serve as a molecular switch to modulate the induction of neural or germline fates by turning off *SOX2* during early human development ([Figure 7](#fig7){ref-type="fig"}E). The BMP4/PRDM1/SOX2 regulatory axis identified in this study may also provide a mechanistic clue to elucidate the molecular mechanisms underlying the suppression of neural development by BMP4 signaling ([@bib17]).

The study of germline development from hESCs has been hampered by the lack of proper protocols for efficient germline induction and/or selection from differentiating hESCs. Previous approaches, including combined growth factor/cytokine stimulation ([@bib8]) and human fetal gonadal cell coculture ([@bib32]), have shown promising effects on germline induction of hESCs and/or hiPSCs. Furthermore, advances in generating transgenic hESCs/hiPSCs harboring germline reporters, such as VASA ([@bib23]) and OCT4 ([@bib8]), have also enabled us to enrich the potential germ cell populations from differentiating PSCs. Nevertheless, the generation of germ cells from hESCs/hiPSCs by the aforementioned protocols is still not satisfactory. In this study, we provide multiple lines of evidence demonstrating that ectopic expression of PRDM1 in hESCs is sufficient to promote the germline program, resulting in the generation of increased numbers of VASA-expressing PGCs during in vitro differentiation. In addition to promoting germ cell marker expression, we detected a small number of cells capable of expressing the meiotic marker SCP3 after ectopic expression of PRDM1. Furthermore, the decreased expression of *DNMT3b* in the differentiated cells overexpressing PRDM1 suggests that PRDM1 may contribute to somatic-to-germline epigenomic reprogramming by promoting the erasure of DNA methylation. However, we did not observe a significantly increased number of cells exhibiting the ability to complete meiosis as judged by haploidy of two chromosome FISH probes. This suggests that, in contrast to the function of previously reported factors, such as DAZ and BOULE ([@bib23]), PRDM1 is not fully competent to promote the later stages of meiosis and development of haploid gametes. These results suggest that PRDM1 acts as an early rather than late germline effector. Our studies thus provide an induction system that will be beneficial for initiating early gem cell specification and subsequent germ cell generation by hESCs/hiPSCs.

Experimental Procedures {#sec4}
=======================

Collection of Human Fetal Samples {#sec4.1}
---------------------------------

Human fetal tissues were obtained from women undergoing an induced termination of pregnancy, with the approval of the Human Subject Research Ethics Committee of Academia Sinica and of National Taiwan University Hospital. The weeks of gestational age were estimated by ultrasound and by measurement of the foot length. Fetal samples obtained from abortus between weeks 16 and 22 of gestational age, without morphological abnormality, were immediately fixed in 10% buffered formalin and then processed for IHC staining.

Culture and Differentiation of hESCs {#sec4.2}
------------------------------------

The conditions used to maintain human EC cell lines are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}. NTU1 hESCs were described previously ([@bib6]). They were cultured on mitotically inactivated mouse embryonic fibroblast (MEF) feeder layers in primate ESC culture medium (ReproCELL) and 5 ng/mL human recombinant basic fibroblast growth factor (bFGF; Invitrogen). H9 hESCs (NIH code [WA09](ncbi-geo:WA09){#intref0010}, [46XX](ncbi-geo:46XX){#intref0015}) were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 (1:1) supplemented with 20% KnockOut serum replacement (Invitrogen) and 5 ng/mL bFGF (Invitrogen) on the MEF feeders. ESCs were subcultured by mechanical scraping and then transferred to fresh MEF feeder cells in ESC media weekly. During differentiation, the hESC split colonies were transferred to dishes coated with 10% Pluronic F-127 (Sigma) for suspension culture/embryoid body formation for 3 days. They were then replated on dishes coated with 0.1% gelatin (Sigma) for adherent culture, and incubated in differentiation media (DMEM from Invitrogen supplemented with 15% fetal bovine serum, 1% nonessential amino acid, 1% L-glutamine, and 0.5% antibiotics). In some experiments, adherent cultures were added with 100 ng/mL BMP4 (R&D Systems) and 50 ng/mL WNT3A (R&D Systems) in differentiation media. Cells were harvested for analysis at the indicated days within the range of not less or more than 36 hr as described in the text. The generation and maintenance of the *OCT4*-EGFP transgene reporter H9:*OCT4*-EGFP were described in a previous report ([@bib8]). H9:OCT4-EGFP cells were spontaneously differentiated on the indicated days. For qRT-PCR analysis, EGFP^+^ cells were sorted by FACS Aria (BD Biosciences). For immunofluorescence staining, EGFP^+^ cells were enriched by manual scraping and then replated on gelatin-coated coverslips.

IHC and Immunofluorescence Staining {#sec4.3}
-----------------------------------

Paraffin-embedded samples were sectioned at 3 μm. The tissue sections were then mounted on glass slides at 60°C for 10 min, followed by deparaffinization and rehydration as previously described ([@bib2]). Detailed procedures are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}. The procedures for immunofluorescence staining were performed essentially as described previously ([@bib38]) and the detailed protocol is described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Meiotic Spreads, Meiotic Marker Staining, and FISH {#sec4.4}
--------------------------------------------------

Detailed protocols are provided in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

RT-PCR, qRT-PCR, and Immunoblotting {#sec4.5}
-----------------------------------

Detailed protocols are provided in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Generation of Lentiviral Vector and Transduction {#sec4.6}
------------------------------------------------

The lentiviral vectors used in this study, the procedure for preparing lentiviral vectors, and transduction are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

ChIP, Transfection, and Luciferase Reporter Assay {#sec4.7}
-------------------------------------------------

Detailed procedures are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Microarray, Comparison with External Gene-Expression Microarray Data, and GO Analysis {#sec4.8}
-------------------------------------------------------------------------------------

Detailed procedures of microarray analysis and bioinformatic analysis to compare the gene-expression profiles of hESCs transduced with GFP-PRDM1 and GFP vectors with other tissues are described in [Supplemental Experimental Procedures](#app3){ref-type="sec"}.

Statistics {#sec4.9}
----------

All of the quantitative analyses were performed by Prism (GraphPad statistics software) and presented as the mean value ± SEM. The statistical significance was determined by two-tailed Student's t tests; p \< 0.05 was considered significant (^∗∗∗^p \< 0.001; ^∗∗^p \< 0.01; ^∗^p \< 0.05).

Accession Numbers {#app1}
=================

The accession number for the microarray data reported in this paper is [GSE53283](ncbi-geo:GSE53283){#intref0020}.

Supplemental Information {#app3}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S5, and Table S3Table S1. Differential Gene Expression in GFP-PRDM1-Transduced H9 hESCsTable S2. Gene Ontology Analysis of Differentially Expressed Genes in GFP-PRDM1-Transduced H9 hESCs
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![PRDM1 Is Expressed in Human Fetal Gonads\
(A) IHC staining of the indicated human embryonic tissues isolated from an 18-week-old male abortus shows the expression of PRDM1 in fetal testis. Sections were also counterstained with eosin. Scale bar, 100 μm.\
(B) IHC staining of human fetal gonads isolated from two female and two male abortus at the indicated age with anti-PRDM1, anti-OCT4, and anti-VASA antibodies. Scale bar, 30 μm.](gr1){#fig1}

![PRDM1 Is Expressed in Germline Lineage Spontaneously Differentiated from hESCs\
(A) qRT-PCR for the indicated mRNA isolated from H9 hESCs plated for spontaneous differentiation on the indicated days.\
(B) Immunofluorescence staining of H9 hESCs plated for spontaneous differentiation with indicated antibodies on indicated days. DAPI was used as the nuclear counterstain. Scale bar, 30 μm.\
(C) qRT-PCR for the indicated mRNA isolated from NTU1 hESCs plated for differentiation by adherent culture on the indicated days.\
(D) Immunofluorescence staining of NTU1 hESCs with the indicated antibodies and DAPI at 5, 10, and 20 days after differentiation by adherent culture. Scale bar, 30 μm.\
(E) qRT-PCR for the levels of *PRDM1* and *VASA* mRNA in sorted EGFP^+^ cells produced by H9:*OCT4-*EGFP plated for differentiation on the indicated days. The experimental flowchart is illustrated. Results in (A), (C), and (E) are the mean ± SEM of three independent experiments.\
See also [Figure S1](#app3){ref-type="sec"}.](gr2){#fig2}

![PRDM1 Is Required for BMP4- and WNT3A-Induced Germ Cell Formation in hESCs\
(A) Immunofluorescence staining of H9 hESCs treated with BMP4 (100 ng/mL) and WNT3A (50 ng/mL) for the indicated days using DAPI and the indicated antibodies. Scale bar, 30 μm. Arrows indicate PRDM1^+^/OCT4^+^ cells.\
(B) qRT-PCR analysis showed the expression of the indicated mRNA in H9 hESCs exposed to BMP4 and WNT3A treatment for the indicated days. Relative fold was compared with spontaneously differentiated cells without BMP4 and WNT3A treatment.\
(C) qRT-PCR analysis showed the expression of the indicated mRNA in H9 hESCs treated with BMP4 (B) and WNT3A (W) in the presence or absence of NOGGIN (250 ng/mL) and DKK1 (500 ng/mL) for 5 days. Relative fold was compared with the levels of mRNA indicated in cells without treatment with BMP4 and WNT3A (mock).\
(D) qRT-PCR for the indicated mRNA isolated from BMP4- and WNT3A-treated shControl or shPRDM1-expressing H9 cells on day 10. Relative fold was compared with the shControl group.\
(E) Immunofluorescence staining of DAPI, PRDM1, and VASA in control and PRDM1-KD (GFP^+^) cells 5 days and 10 days after BMP4 and WNT3A treatment. Scale bar, 30 μm. The values in (B)−(D) are represented as the mean ± SEM of three independent experiments.\
See also [Figure S2](#app3){ref-type="sec"}.](gr3){#fig3}

![Ectopic Expression of PRDM1 in hESCs Enhances BMP4- and WNT3A-Induced Germline Differentiation\
(A) Immunofluorescence staining of VASA shows that in comparison with GFP-expressing cells, GFP-PRDM1-expressing cells generated enhanced VASA signals after exposure to BMP4 or WNT3A for 2 weeks. The images shown in the selected boxes are enlarged in the upper-left corner of each panel. Scale bar, 100 μm.\
(B) Immunofluorescence staining shows the formation of SCP3^+^ cells in GFP-PRDM1-expressing H9 cells treated with BMP4 and WNT3A for 2 weeks. Scale bar, 10 μm.\
(C) Percentage of cells showing punctate, elongated, or negative stains for SCP3 within 300 GFP^+^ or 300 GFP-PRDM1^+^ H9 cells treated with BMP4 and WNT3A on day 14.\
(D) FISH results for chromosome 16 (green) and X (red) in GFP-PRDM1- or GFP-expressing cells as described in (B). DP, diploid; HP, haploid; TP, tetraploid. Scale bar, 10 μm.\
See also [Figure S2](#app3){ref-type="sec"}.](gr4){#fig4}

![Ectopic Expression of PRDM1 in hESCs Enhances Embryonic Germ Cell Differentiation\
(A) Immunofluorescence staining shows that ectopic expression of PRDM1 coexpressed with OCT4^+^ cells, and produced STELLA^+^ and NANOS3^+^ (indicated by the arrowheads), and VASA^+^ (indicated by the arrows) cells in H9 hESCs. GFP-PRDM1- or GFP-expressing H9 colonies were picked under the fluorescence microscope 7 days after lentiviral transduction and the GFP^+^ cells were seeded onto a new feeder layer, followed by the immunofluorescence staining and DAPI staining at week 2. Scale bar, 30 μm.\
(B) qRT-PCR for the indicated mRNA using cDNA from isolated GFP^+^ H9 cells that expressed either GFP-PRDM1 or GFP for 2 weeks as described in (A). Results are the mean ± SEM from three independent experiments.\
(C) GO analysis showed a significant enrichment of genes related to differentiation and development following PRDM1 expression in H9 cells. The list shows the top ten enriched GO terms based on the p value. The percentage represents the relative numbers of genes belonging to each category within the top ten enriched GO terms of 1,071 preferentially expressed genes.\
(D) Multidimensional scaling plot of the 51 global gene-expression profiles of selected stem cells and tissue samples. Distances between data points approximate dissimilarity (1 − correlation coefficient) of their expression profiles.\
(E) The average correlation coefficients between the expression profiles of H9 hESCs transduced with GFP- or GFP-PRDM1-expressing vector and fetal ovary (left) or testis (right) tissues at the indicated developmental time points.](gr5){#fig5}

![Enforced PRDM1 Expression Represses *SOX2*\
(A) qRT-PCR shows the relative mRNA levels of *OCT3/4*, *SOX2*, and *NANOG* in H9 cells 7 days after transduction with GFP-PRDM1- or GFP-expressing lentiviral vectors.\
(B) Immunofluorescence staining of OCT4, SOX2, or NANOG in H9 cells expressing GFP-PRDM1 or GFP for 7 days. Scale bar, 100 μm.\
(C) Schematic representation of seven potential PRDM1-binding sites on the *SOX2* 5′ flanking region. The transcriptional start site (+1) is indicated.\
(D) ChIP showed the binding of PRDM1 in the *SOX2* 5′ flanking region in NCCIT EC cells expressing GFP-PRDM1. NCCIT EC cells were transduced with either GFP-PRDM1 or GFP producing lentiviral vectors. Two days later, ChIP analysis was performed. Immunoglobulin G (IgG) was used as isotype control antibody. The 3′ UTR of *SOX2* and *CIITA* gene loci and *CIITA* promoter III were used as the negative control and positive loci for PRDM1 binding, respectively. Results (mean ± SEM) are triplicate data for one representative experiment of three independent experiments.\
(E and F) The luciferase reporter assay showed that multiple PRDM1-binding sites on the *SOX2* 5′ flanking region are involved in PRDM1-mediated suppression. Relative luciferase activity was measured using lysates from NCCIT EC cells transfected with PRDM1 expression or control vector, equal molar of the indicated luciferase reporters driven by various lengths of *SOX2* 5′ flanking region (E) or *SOX2* 5′ flanking region containing various PRDM1-binding-site mutants (m) (F) together with thymidine kinase promoter-*Renilla* luciferase reporter plasmid (RL-tk). Luciferase activity assay was analyzed 48 hr later. Results in (A), (E), and (F) are the mean ± SEM of three independent experiments.\
See also [Figure S3](#app3){ref-type="sec"}.](gr6){#fig6}

![The PRDM1/SOX2 Regulatory Axis Controls Germ Cell versus Neural Cell Fate in BMP4- and WNT3A-Treated hESCs\
(A) shControl or shPRDM1 lentiviral vectors were transduced into BMP4- and WNT3A-treated H9 cells. Alteration of mRNA expression was quantified by qRT-PCR. Relative values were calculated by comparing the mRNA levels of the indicated genes in PRDM1-KD cells at the indicated days with shControl-transduced cells on day 0.\
(B) Immunofluorescence staining indicated that shPRDM1-transduced, but not shControl-transduced, cells showed enhanced SOX1, NESTIN, TUJ1, and MAP2 at the indicated days after BMP4 and WNT3A treatment. Scale bar, 30 μm.\
(C) Sorted GFP^+^ H9 cells that were expressing control GFP alone or SOX2 and GFP simultaneously were treated with BMP4 and WNT3A, followed by qRT-PCR analysis to detect the indicated genes at various days. The fold change was plotted relative to the values obtained from the control vector-transduced cells on day 0.\
(D) Immunofluorescence staining showed the expression of exogenous SOX2, reduced expression of PRDM1 and VASA, and increased expression of SOX1, LHX2, TUJ1, and MAP2 as compared with control GFP^+^ cells at the indicated days after BMP4 and WNT3A treatment. Scale bar, 30 μm. Results in (A) and (C) are the mean ± SEM of three independent experiments.\
(E) Working model of the function of PRDM1 in germline differentiation by hESCs. BMP4- and WNT3A-mediated upregulation of PRDM1 transcriptionally suppresses *SOX2*, thereby inducing the activation of germline fate and preventing the neural program. Dashed lines indicate that the detailed signaling pathways leading to the induction of PRDM1 have not been characterized.\
See also [Figures S4](#app3){ref-type="sec"} and [S5](#app3){ref-type="sec"}.](gr7){#fig7}
